|Market Cap (Intraday)||1.12B|
|2yr Forward PE||N/A|
Mannkind Corp Stock, NASDAQ:MNKD
MannKind Corp. operates as a biopharmaceutical company. It focuses on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Westlake Village, CA.